Recent Comments

Psychologists Study Zero-Gravity Effects on the Human Brain (1)
computer user 14 wrote: So your doing this experiment to see if zero-g hel… [More]
Insertion of tiny heart pump without surgery (1)
Md. Saif Uddin wrote: My father is aged 57 and has TVD (Tripple Vessel D… [More]
Saffron could stop blindness and cure eye disease (2)
Marilyn wrote: Do you know where I could find this article in Fre… [More]
Department of Health announces adult autism strategy (1)
Cindy Wigglesworth wrote: My 18 year old son has Asperger's, ADHD, and anger… [More]
Concerns raised over safety of 'electronic cigarettes' (7)
carlo wrote: I had a little sore throat too. I think it was bec… [More]
Skin specialists issue warning about tan jab (1)
Melanotan wrote: Because of the side effects that they found out in… [More]

<< Canadian Arthritis Network to host 2009 Annual Scientific Conference in Vancouver | Low-level laser therapy increases tumour growth in skin cancer >>

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

19. November 2009 22:41

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.

“We have had a long and productive drug discovery relationship with Organon and Schering-Plough (which acquired Organon in November 2007) over the years for a range of research programs,” said John L. Higgins, President and Chief Executive Officer of Ligand. “These activities reflect Ligand’s strong R&D engine and the potential of our partnership portfolio.”

Source: Ligand Pharmaceuticals Incorporated

94c2a419-977e-42b6-bf76-4843e63fe7a8|0|.0

Posted in: Business / Finance

Tags: Anemia, Arthritis, Asthma, Biotechnology, Cell, Osteoporosis, Pfizer, Psoriasis, Rheumatoid Arthritis

Amgen receives worldwide rights to Array’s small-molecule glucokinase activator programArray BioPharma Inc. and Amgen Inc.(NASDAQ: AMGN) today announced that they entered into an agreemen...Exelixis to present 13 abstracts of its development candidates at the 2009 AACR-NCI-EORTC ConferenceExelixis, Inc. announced today that thirteen abstracts related to the company’s development candidat...RA patients who adhere to their prescription drug regimen have better outcome: StudyRheumatoid arthritis (RA) patients who regularly adhere to their prescription drug regimen have fewe...GENova Biotherapeutics and Korean university sign strategic partnership agreementGENova Biotherapeutics Inc. ("GENova") today announced that it has signed a LOI for a strategic part...Massage therapy eases sickle cell disease pain in childrenMassage offers both physical and psychological benefits and is used at Nationwide Children’s Hospita...High gas prices lead U.S. residents who travel far, frequently for medical treatment to skip, delay appointmentsMany U.S. residents with illnesses who must travel frequently or long distances for treatment are fo...Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal womenAromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopaus...Inhaled corticosteroids can reduce breathing problems in children at high risk for asthmaStudies in older children and adults show that the most effective long-term control medicine for per...Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestineAccording to a study published today in the American Gastroenterological Association (AGA) journal C...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Recent Articles

Free!

Recent Comments

Twitter

Information

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Medical News Cloud

Recent Articles